STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
SRDX SURMODICS INCORPORATED StockScouter® Report
6
StockScouter® Score
SURMODICS INCORPORATED, a small cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with slightly less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
- Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral
Concerns
- The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative
- Short-term relative price momentum exhibits meaningful weakness. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
A
C
C
C